News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
612,741 Results
Type
Article (48536)
Company Profile (95)
Press Release (564101)
Multimedia
Podcasts (174)
Webinars (27)
Section
Business (160919)
Career Advice (2488)
Deals (30278)
Drug Delivery (169)
Drug Development (74545)
Employer Resources (161)
FDA (16796)
Job Trends (12796)
News (290109)
Policy (31547)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (6)
Academia (2475)
Academic (1)
Accelerated approval (60)
ADA (46)
Adcomms (42)
Allergies (188)
Alliances (40552)
ALS (224)
Alzheimer's disease (1915)
Antibody-drug conjugate (ADC) (542)
Approvals (17157)
Artificial intelligence (746)
ASCO (328)
Autoimmune disease (358)
Automation (54)
Bankruptcy (322)
Best Places to Work (9657)
BIO (67)
BIOSECURE Act (23)
Biosimilars (247)
Biotechnology (62)
Bladder cancer (212)
Brain cancer (74)
Breast cancer (770)
Cancer (6240)
Cardiovascular disease (531)
Career advice (2109)
Career pathing (49)
CAR-T (345)
CDC (77)
Celiac Disease (2)
Cell therapy (972)
Cervical cancer (55)
Clinical research (65707)
Collaboration (2112)
Commercialization (1)
Company closure (7)
Compensation (1531)
Complete response letters (110)
COVID-19 (2818)
CRISPR (116)
C-suite (1203)
Cystic fibrosis (160)
Data (8468)
Decentralized trials (3)
Denatured (39)
Depression (196)
Dermatology (99)
Diabetes (662)
Diagnostics (6207)
Digital health (55)
Diversity (8)
Diversity, equity & inclusion (43)
Drug discovery (360)
Drug pricing (242)
Drug shortages (34)
Duchenne muscular dystrophy (320)
Earnings (69408)
Editorial (81)
Employer branding (20)
Employer resources (145)
Events (92560)
Executive appointments (1064)
FDA (20889)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (33)
Funding (1694)
Gene editing (250)
Generative AI (65)
Gene therapy (785)
GLP-1 (1235)
Government (4483)
Grass and pollen (8)
Guidances (415)
Healthcare (16130)
Hematology (181)
HIV (93)
Huntington's disease (68)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (117)
Immunology and inflammation (359)
Immuno-oncology (109)
Indications (215)
Infectious disease (3189)
Inflammatory bowel disease (221)
Inflation Reduction Act (14)
Influenza (141)
Intellectual property (311)
Interviews (465)
IPO (14970)
IRA (58)
Job creations (3400)
Job search strategy (1713)
JPM (69)
Kidney cancer (23)
Labor market (112)
Layoffs (657)
Leadership (52)
Legal (7487)
Liver cancer (106)
Longevity (30)
Lung cancer (828)
Lymphoma (473)
Machine learning (64)
Management (54)
Manufacturing (1135)
Marketing (5)
MASH (221)
Medical affairs (1)
Medical device (12409)
Medtech (12564)
Mergers & acquisitions (16556)
Metabolic disorders (1764)
mRNA (259)
Multiple sclerosis (187)
NASH (23)
Neurodegenerative disease (486)
Neuropsychiatric disorders (126)
Neuroscience (3573)
Neurotech (2)
NextGen: Class of 2026 (5269)
Non-profit (3440)
Now hiring (52)
Obesity (862)
Opinion (334)
Ovarian cancer (230)
Pain (259)
Pancreatic cancer (352)
Parkinson's disease (399)
Partnered (33)
Patents (641)
Patient recruitment (767)
Peanut (64)
People (49859)
Pharmaceutical (30)
Pharmacy benefit managers (36)
Phase 1 (19800)
Phase 2 (28499)
Phase 3 (22778)
Pipeline (9781)
Policy (394)
Postmarket research (2596)
Preclinical (8140)
Press Release (53)
Prostate cancer (348)
Psychedelics (71)
Radiopharmaceuticals (329)
Rare diseases (1265)
Real estate (4833)
Recruiting (66)
Regulatory (25711)
Reports (48)
Research institute (2267)
Resumes & cover letters (417)
Rett syndrome (47)
RNA editing (25)
RSV (88)
Schizophrenia (191)
Series A (298)
Series B (221)
Service/supplier (7)
Sickle cell disease (123)
Special edition (30)
Spinal muscular atrophy (157)
Sponsored (53)
Startups (3066)
State (1)
Stomach cancer (21)
Supply chain (134)
Tariffs (104)
The Weekly (133)
Vaccines (1269)
Venture capital (138)
Weight loss (595)
Women's health (123)
Worklife (25)
Date
Today (75)
Last 7 days (383)
Last 30 days (2000)
Last 365 days (29559)
2026 (16172)
2025 (29336)
2024 (32716)
2023 (36595)
2022 (47279)
2021 (50859)
2020 (47967)
2019 (38869)
2018 (29463)
2017 (29520)
2016 (27524)
2015 (30257)
2014 (23594)
2013 (19308)
2012 (20872)
2011 (21662)
2010 (20055)
Location
Africa (726)
Alabama (89)
Alaska (6)
Arizona (297)
Arkansas (12)
Asia (37215)
Australia (6201)
California (13346)
Canada (3313)
China (1484)
Colorado (523)
Connecticut (620)
Delaware (415)
Europe (89460)
Florida (2033)
Georgia (412)
Hawaii (4)
Idaho (46)
Illinois (1052)
India (92)
Indiana (535)
Iowa (25)
Japan (585)
Kansas (118)
Kentucky (41)
Louisiana (45)
Maine (78)
Maryland (1608)
Massachusetts (9696)
Michigan (314)
Minnesota (692)
Mississippi (5)
Missouri (152)
Montana (18)
Nebraska (26)
Nevada (142)
New Hampshire (70)
New Jersey (3605)
New Mexico (19)
New York (3471)
North Carolina (1691)
North Dakota (8)
Northern California (6850)
Ohio (373)
Oklahoma (20)
Oregon (34)
Pennsylvania (2556)
Puerto Rico (25)
Rhode Island (52)
South America (1103)
South Carolina (85)
South Dakota (2)
Southern California (5258)
Tennessee (209)
Texas (2098)
United States (46759)
Utah (335)
Vermont (2)
Virginia (328)
Washington D.C. (76)
Washington State (1039)
West Virginia (4)
Wisconsin (136)
Wyoming (2)
612,741 Results for "symrise s r l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Sanofi’s R&D head exits, with AI biotech Xaira’s exec stepping in
About two months into CEO Belén Garijo’s new tenure, Sanofi’s R&D chief has departed, with Xaira’s chief medical officer set to take charge of the pharma’s pipeline.
June 22, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Symrise and Aplantex Confirm an Agreement to Establish a Partnership
October 15, 2025
·
2 min read
Press Releases
Anaergia S.r.l. Expands Scope at Three Biomethane Facilities Being Built for QGM S.á.r.l. in Italy, Increasing Contracts by C$17 Million
March 17, 2026
·
3 min read
Press Releases
Disclosure of a transparency notification from AOC Pharma S.à r.l.
March 1, 2026
·
2 min read
Press Releases
Inside the 98 Percent: L7 Informatics on the Operational Harness That Determines Pharma’s Agentic AI Outcomes
L7 Informatics CEO, Vasu Rangadass, Ph.D., examines the architectural principle separating pharmaceutical AI experimentation from enterprise-scale deployment.
June 12, 2026
·
1 min read
Press Releases
L7 Informatics Makes the Case for an Agentic Operating System as the Strategic Foundation for Regulated Process Industries
L7 CEO Vasu Rangadass, Ph.D., argues that regulated process industries have reached the limits of point-solution modernization and must pivot to unified orchestration to unlock the promise of agentic AI.
June 15, 2026
·
1 min read
Opinion
The real potential of PD-(L)1×VEGF bispecifics may be outside lung cancer
PD-(L)1×VEGF bispecifics have emerged as a closely watched new class in immuno-oncology, with multiple candidates advancing through trials in lung cancer. But the potential of these drugs may be highest in cancers where angiogenesis and immune escape are tightly intertwined.
May 28, 2026
·
6 min read
·
Souro Chowdhury
Press Releases
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.
January 7, 2026
·
5 min read
Government
US launches investigation into German drug pricing, citing unfair R&D burden
The U.S. government has argued that it pays too much of biopharma R&D costs, demanding that other high-income countries contribute fairly to global innovation efforts.
June 19, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Lantern Pharma Reports HARMONIC™ Data Showing LP-300 Progression-Free Survival Benefit Deepens with Treatment Duration in EGFR Exon 21 L858R Lung Cancer
June 2, 2026
·
11 min read
1 of 61,275
Next
